Printer Friendly

Articles from The Fly (April 2, 2019)

1-150 out of 150 article(s)
Title Author Type Words
'Anthem' development marked by mismanagement, worker departures, Kotaku says. 289
A Disappointing U.S. Treasury Receipt Path. 113
Achieve Life Sciences announces completion of second DSMB review of ORCA-1 trial. 193
Adaptimmune says SRC endorses advancing ADP-A2AFP to Cohort 2. 229
ADMA Biologics reports FDA approves Asceniv intravenous immune globulin. 204
Aecom announces $750M contract extension with DOE in South Carolina. 103
Agenus announces dosing of first patient in clinical trial of AGEN1181. 150
Aggressive call buying in Xtrackers Harvest CSI 300 China AShares ETF. 105
Airlines needed some good news, and Delta delivered, says Stephens. 170
Akoustis announces new WiFi filter supply agreement. 113
Allergan, Molecular Partners announce results from MAPLE study of abicipar. 185
American Express reaffirms FY19 adjusted EPS view $7.85-$8.35, consensus $8.13. 101
American Express, Delta Air Lines sign 11-year renewal extending SkyMiles cards. 138
Amira Nature Foods regains compliance with NYSE listing requirements. 121
AngioDynamics reports Q3 adj. EPS 19c, consensus 21c. Financial report 133
Apple tried hard to woo NY Times, WaPo to Apple News+, Vanity Fair reports. 175
Apple's 2019 iPhones to feature two-way wireless charging, MacRumors reports. 102
Aptevo Therapeutics presents preclinical data on APVO436, ALG.APV-527 at AACR. Clinical report 359
Apyx Medical reaffirms 2019 revenue outlook $25M-$26M, consensus $25.47M. 135
AquaBounty, Intrexon subsidiary announce ECCC approval for Rollo Bay facility. 159
Asian Market Wrap:. 203
Atlanta Fed's Q1 GDPNow estimate was lifted again to 2.1%. 116
Average new vehicle interest rates on car loan highest in decade, Edmunds says. 246
BARDA decides not to advance Pfenex anthrax programs. 121
BARDA decision has no negative read through for Pfenex, says JMP Securities. 101
BARDA passing on Pfenex good news for Emergent, says Wells Fargo. 131
Big banks compete for small deals as merger boom slows, WSJ reports. 119
Biofrontera provides information on public tender offer by Maruho Deutschland. 110
BioTelemetry pullback on iRhythm concerns a buying opportunity, says Benchmark. 109
BlackRock makes changes to senior leadership ranks, Reuters reports. 121
Boeing moved 'haltingly' to make fixes to 737 MAX between accidents, WSJ says. 107
BofA CEO dismisses suggestion of Fed cutting interest rates, CNBC says. 165
Bristol-Myers reports long-term survival results from pooled analyses of Opdivo. Financial report 296
Calithera Biosciences presents preclinical CB-708 data at AACR. 138
Call buyer in Party City with shares falling to 52-week lows. 101
Care.com downgraded to Neutral from Buy at BTIG. 122
Carvana advances over 4% after announcing expansion of California market. 119
Celldex presents interim data from CDX-1140 at AACR. 259
Chanticleer Holdings announces exclusive partnership with DoorDash. 105
Chembio Diagnostics enters agreement with Perseus Science Group for TBI test. 105
Clovis announces interim results from Rubraca Phase 2 study. 690
Concho to receive approx. $300M in net proceeds from Oryx I sale. 170
Cray supercomputers to include new Intel Xeon scalable processors. 121
CSG launches blockchain technology lab for business support systems industry. 207
Cyclerion Therapeutics begins trading, announces plan for five sGC programs. 139
Daimler CEO says Boeing debate shows challenge for autonomous tech, Reuters says. 131
Discovery plans nonfiction subscription streaming services, WSJ reports. 101
Dow Inc. initiated with an Outperform at Credit Suisse. 116
DPW Holdings terminates At-The-Market Issuance Sales Agreement. 106
Dynavax presents Phase 1b data on inhaled DV281 TLR9 agonist. 288
Esperion announces JAHA publication of bempedoic acid Phase 3 study. Clinical report 191
Euro$ interest rate futures are above lows. 144
Evoke Pharma's NDA for Gimoti not approved by FDA. 150
Exxon Mobil invests in Singapore integrated complex. 228
Fathom Events, Meteor 17 form strategic partnership for content development. 133
FDA to hold hearing on potential regulatory pathways for cannabis products. 327
Fed funds futures are rallying. 162
Fiat Chrysler reports March U.S. auto sales down 7.3% to 200,307 vehicles. Financial report 137
Flexion announces Zilretta independent review data published. Clinical report 465
Fly Intel: Pre-market Movers. 226
Fly Intel: Top five analyst downgrades. 195
Fly Intel: Top five analyst initiations. 119
Fly Intel: Top five analyst upgrades. 206
Foristar acquires two renewable natural gas facilities in Pennsylvania. 176
FTC Chairman 'eager' for Democratic support for Facebook deal, Politico reports. 112
Future FinTech announces operational updates of Chain Cloud Mall. 149
FX Update: The dollar has regained an underlying bid. 321
FX Update: The dollar has traded firmer against most currencies. 322
General Motors reports Q1 U.S. sales down 7.0% to 665,840 vehicles. Financial report 151
Governor Cuomo adamant about legal pot law by June, NY Post says. 121
Green Dot pullback brings good buying opportunity, says Jefferies. 117
Guggenheim downgrades Wingstop to Neutral, cuts target to $72. 105
Gulf Resources receives PRC approval to open two bromine factories. 210
Honda reports March U.S. sales up 4.3% to 148,509 vehicles. Financial report 104
Hubbell spin off of lighting business would be good idea, says JMP Securities. 122
IMAC to acquire ISDI Holdings. 121
Inovio says dBiTEs generated potent anti-tumor activities in preclinical study. Report 142
Intel announces general availability of 2nd-Generation Xeon Scalable processors. 252
Jefferies discusses potential auto mergers, downgrades VW to Hold. 109
Jefferies stays negative on frac sand despite raising price targets. 151
Jounce Therapeutics reports new clinical data on vopratelimab. 355
Kellogg divestiture of Keebler brand makes strategic sense, says Morgan Stanley. 116
Knowles shares fully valued at current levels, says JPMorgan. 110
Lamb Weston reports Q3 adjusted EPS 95c, consensus 82c. Financial report 146
Lamb Weston sees FY19 net sales growth rate in the high single digits. 180
Lear to acquire Xevo for $320M. 149
Major oil should be interested in Torchlight Energy Resources, says Roth Capital. 105
McDermott announces joint venture with Zamil Offshore. 107
Meridian Bioscience sees FY19 non-GAAP EPS 60c-65c, consensus 76c. 119
Meridian Bioscience sees Q2 revenue $50.0M, consensus $56.37M. Financial report 222
Microsoft, BMW Group launch Open Manufacturing Platform. 209
Money market rates have eased off from quarter-end and settlement pressures. 117
MoneyGram,First Abu Dhabi Bank's payit Wallet team for UAE's 1st digital wallet. 133
Myriad Genetics to present data on performance of its prenatal tests at ACMG. 215
NanoString announces co-marketing agreement with Leica Biosystems. 128
Netflix recent underperformance brings good buying opportunity, says JPMorgan. 206
NewLink Genetics presents NLG207 results at AACR. 215
NIO calls lead puts 4:1 as the rebound effort continues. 115
NIO Inc. reports 3,989 ES8 deliveries in Q1. 136
Novartis announces Chinese approval of Cosentyx for psoriasis patients. 105
Ocular Therapeutix announces FDA acceptance of supplemental NDA for DEXTENZA. 227
Pacific Biosciences announces retrospective study on PacBio sequencing published. 318
Piper continues to believe Apyx Medical will receive 510k clearance. 117
Puma Biotechnology buyout chances 'about the same,' says Cantor Fitzgerald. 122
Qorvo upgraded to Overweight on increased confidence after Asia trip at KeyBanc. 116
Quest, LabCorp upgraded to Buy ahead of UnitedHealth lab network rollout. 117
Rapid7 acquires NetFort. 142
Regulators say Wynn Resorts execs tried to protect Steve Wynn, WSJ reports. 127
Ribbon Communications extends partnership with Neustar. 137
Sangamo price target raised to $34 from $24 at Wells Fargo. 135
Sangamo signs option agreement with Brammer Bio. 129
Sangamo, Pfizer announce Phase 1/2 interim data for SB-525 gene therapy. 392
Scholar Rock presents additional preclinical data on SRK-181-mIgG1. 222
Seaport Global starts Lyft with Sell rating, $42 price target. 133
Sempra Energy unit SoCalGas to replace 20% of natural gas supply with RNG. 181
Senior Housing and Five Star Senior Living to restructure business arrangements. 252
Senior Housing and Five Star Senior Living to restructure business arrangements. 252
Stifel says abicipar improvement not enough to make Allergan drug competitive. 109
Stonepeak Infrastructure Partners to acquire Oryx Midstream for $3.6B. 182
SunOpta to acquire Sanmark in transaction valued at EUR3M. 138
Synopsys reaffirms Q2, FY19 guidance at investor day. 103
Synthesis Energy Systems engages advisors to explore strategic alternatives. 152
TJX announces 18% increase in common dividend to 23c per share. 172
Today's U.S. February durables report modestly under-performed. 212
Treasury Action: yields aren't far from the lows of the year. 202
Treasury Action: yields steadied below highs. 108
Treasury Market Outlook: core sovereign yields are moderately richer. 213
Treasury Option Action: heavy put buying on bonds. 115
Trillium expands immuno-oncology pipeline with STING agonist program. 108
Triumph Group assigns contract to Aerospace Technologies of Korea. 173
Trovagene presents data from ongoing Phase 2 study of Onvansertib. 178
U.S. durable goods orders dropped 1.6% in February. 145
U.S. equities are on hold either side of unchanged. 213
U.S. equities rolled over after a flat start. 207
U.S. vehicle sales preview:. 103
UGI Corporation cuts FY19 adjusted EPS view to $2.40-$2.60 from $2.75-$2.95. 108
UGI Corporation sees AmeriGas acquisition accretive to EPS beginning in FY20. 221
UGI Corporation to acquire 100% of publicly held units of AmeriGas. 304
UKAR announces GBP4.9B sale of NRAM assets to Citi. 105
UnitedHealthcare, AMA announce new collaboration. 115
Upside call buyers active in Las Vegas Sands. 109
Vivendi says won't use buyback authorization requested at AGM. 105
Wabco appoints Sean Deason as CFO. 113
Walgreens Boots Alliance reports Q2 adj. EPS $1.64, consensus $1.74. Financial report 365
Walmart teams with Google on voice-enabled grocery shopping. 152
Wedbush says 'too early to be overreactive' as Lyft shares drop below IPO price. 167
Wells Fargo's credit rating cut to negative at S&P following CEO departure. 131
WPX Energy to receive approx. $350M in net proceeds for 25% interest in Oryx II. 180
Wynn Resorts calls lead puts 2:1 as shares rally to multi-month highs. 121
Xencor, Astellas enter collaboration for novel bispecific antibody program. 143

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters